The Intracranial Pressure (ICP) monitoring devices are developed with the purpose of measuring the inside of a child’s head. It does so by using a pressure monitor that is inserted within the skull. There are a number of reasons behind using this procedure, the most common among them is after a head injury, trauma, or surgery to the brain. It measures the pressure within the cranium. The monitoring typically stretches to 24 hours, however, it can occasionally be needed for several number of days. The normal ICP pressure level is between 0-10 mm H, while anything greater than 20 mm hg is seen as fatal. The monitoring device is of significant importance for patients suffering from a cranial injury. The injury can be caused due to a result of neurosurgery, stroke, hydrocephalus, or trauma. With an estimated 1.75 million people annually suffering from traumatic brain injuries in North America alone, the diagnostic and post-operative importance of these devices are extremely high. Surgeons use these devices to help save the lives of numerous patients with timely and accurate intervention and diagnosis.

The report published by Market Research Future (MRFR) reveals the global Intracranial Pressure (ICP) monitoring market to grow at a CAGR of 7.1% during the forecast period of 2018 to 2024. The major factors determining this upward slant of the market is the prevalence of various neurovascular diseases like brain aneurysm and arteriovenous malformations (AVMs). The rising demand for therapeutics coupled with the surging healthcare expenditure in various countries is most likely to have a positive influence on its market growth in the forthcoming years.

Competitive Analysis

The major players in the global Intracranial Pressure Monitoring market are Natus Medical Incorporated, RAUMEDIC Inc., Spiegelberg GmbH & Co.KG, Integra LifeSciences Corporation, Medtronic Plc., Sophysa SA, Boston Neurosciences, DePuy Synthes, Terumo Corporation, and others.

Access Report @ Click Here